Search
Search

dsRNA Removal for IVT mRNA |
dsRNA is an unavoidable byproduct of in vitro transcription (IVT) that activates innate immune pathways, suppresses translation, and introduces variability into downstream experiments. Removing dsRNA is especially important for sensitive cell lines and in vivo applications, yet existing methods may help provide incomplete removal or reduce mRNA yield and integrity. This challenge led us to develop a solution designed to selectively remove dsRNA while preserving mRNA yield and integrity.
The Invitrogen MEGAclear dsRNA Removal Kit offers a rapid magnetic bead-based workflow that specifically removes dsRNA contaminants from IVT mRNA with minimal impact on yield and integrity. The result is cleaner mRNA that supports higher protein expression and reduced immunogenicity, giving you greater control and confidence in your experiments across a variety of applications.
During in vitro transcription, RNA polymerases generate the desired single-stranded mRNA transcript from a DNA template, but can also produce unintended double-stranded RNA through RNA-templated transcription, antisense transcription, and self-complementary RNA structures. These dsRNA contaminants can resemble viral dsRNA and trigger cellular innate immune responses. Removing dsRNA helps minimize these unwanted biological effects, giving you greater control over your mRNA quality and supporting more consistent and reliable experimental outcomes.
Figure 1. Formation of dsRNA byproducts during IVT reactions. During IVT, RNA polymerase can generate unintended double-stranded RNA (dsRNA) byproducts. The RNA products can anneal to complementary sequences and serve as a template for the RNA polymerase to produce short dsRNAs or long/loopback dsRNA structures. These byproducts can persist alongside the desired mRNA product and cause unintended immune responses.
The Invitrogen MEGAclear dsRNA Removal Kit uses an engineered protein to selectively bind and capture dsRNA contaminants from IVT reactions, leaving single-stranded mRNA in solution and preserving yield and integrity. Consistent dsRNA removal and high mRNA recovery were observed across a range of transcripts and lengths.
Figure 2. MEGAclear dsRNA Removal Kit efficiently removes dsRNA byproducts while maintaining high mRNA recovery. Various mRNA transcripts, ranging from 0.8 to 5 kb, were generated using the mMESSAGE mMACHINE T7 mRNA Kit with CleanCap Reagent AG and purified using the MEGAclear dsRNA Removal Kit. (A) dsRNA levels following purification. Across the transcripts tested, dsRNA was reduced to below the lower limit of quantification of the ELISA (red dashed line). Untreated indicates that the mRNAs were not treated with the MEGAclear dsRNA Removal Kit. (B) mRNA recovery following dsRNA removal. Purified samples retained high mRNA yields across the different transcripts, with yields remaining above 120 µg (red dashed line).
In sensitive cell lines and animal models, even low levels of dsRNA can trigger innate antiviral responses. dsRNA activates sensors including PKR, MDA5, RIG-I and Toll-like receptors, which can reduce protein translation, increase inflammatory signaling, and decrease cell viability. Removing dsRNA with the MEGAclear dsRNA Removal Kit can improve protein expression while reducing immune activation and inflammation in cell and animal models. This helps support more consistent experimental outcomes across applications such as protein expression, repeated transfections, and gene editing.
Figure 3. The MEGAclear dsRNA Removal Kit improves mRNA expression and reduces inflammatory responses in vitro and in vivo. (A) m1Ψ RFP mRNA was transfected into murine JAWSII immature dendritic cells using Lipofectamine MessengerMAX Transfection Reagent. RFP expression and inflammatory response were compared between untreated mRNA (+dsRNA) and mRNA treated with the MEGAclear dsRNA Removal Kit (–dsRNA). MEGAclear-treated mRNA showed increased RFP expression and reduced levels of the cytokine IP-10/CXCL-10. (B) m1Ψ firefly luciferase (FLuc) mRNA was encapsulated in lipid nanoparticles (LNPs) and administered to mice. At 4 hours post-administration, ex vivo FLuc activity and cytokine/chemokine levels were compared between untreated (+dsRNA) and MEGAclear-treated mRNA (–dsRNA). dsRNA removal increased FLuc expression and reduced induction of inflammatory cytokines and chemokines. Heat-map colors indicate relative cytokine/chemokine levels compared with the PBS control, with warmer colors representing greater induction.
Ion-pair reverse-phase HPLC is widely regarded as the benchmark method for removing dsRNA from IVT mRNA, but it can reduce mRNA recovery and requires specialized instrumentation and expertise. Because HPLC separates RNA based on physicochemical properties rather than specifically recognizing dsRNA, selectivity is limited and mRNA recovery can be affected. The MEGAclear dsRNA Removal Kit provides a simple, selective, magnetic bead–based alternative that reduces dsRNA comparable to HPLC while preserving more mRNA. The result is high-quality mRNA that delivers protein expression and cytotoxicity profiles comparable to HPLC-purified mRNA—without the complexity of chromatography.
Figure 4. MEGAclear dsRNA Removal Kit delivers HPLC-like dsRNA removal while preserving mRNA recovery and expression. Gaussia luciferase (GLuc) mRNA was left untreated (Standard) or purified using either the MEGAclear dsRNA Removal Kit or HPLC. (A) MEGAclear dsRNA Removal Kit reduced dsRNA to levels comparable to HPLC and well below untreated mRNA. Red dashed line is the assay lower limit of quantification. (B) MEGAclear dsRNA removal retained >75% of the input mRNA (red dashed line), whereas HPLC resulted in lower recovery. (C) GLuc expression following transfection of human BJ fibroblasts with purified or untreated mRNA using Lipofectamine MessengerMAX Transfection Reagent. MEGAclear dsRNA removal and HPLC-purified mRNA produced higher and comparable luciferase expression relative to untreated mRNA. Mock-transfected cells served as a negative control. (D) Secretion of the cytokine IP-10 (CXCL10) following transfection. MEGAclear-treated and HPLC-purified mRNA elicited substantially lower inflammatory responses than untreated mRNA; poly(I:C) was included as a positive control for dsRNA-induced inflammation.
The MEGAclear dsRNA Removal Kit integrates easily into standard IVT mRNA synthesis workflows. After the IVT reaction and DNase I treatment, use the MEGAclear dsRNA Removal Kit to selectively capture and remove dsRNA contaminants from solution. Then proceed with a standard mRNA purification step to remove the digested DNA template, unincorporate nucleotides, and proteins. This final clean up step can be done with a kit such as the MEGAclear Transcription Clean-up Kit or Dynabeads RNA Purification Kit.
The MEGAclear dsRNA Removal Kit is compatible with:
For other kits outside of this list, the protocol might require adjustment and experimental testing to achieve the desired dsRNA removal efficiency and/or mRNA recovery.
Double-stranded RNA is an unintended byproduct generated during in vitro transcription. Because it resembles viral RNA, it activates innate immune pathways leading to reduced protein expression and increased inflammatory signaling.
Removing dsRNA improves protein expression, reduces innate immune activation, supports cell viability, and promotes more consistent experimental outcomes.
The MEGAclear dsRNA Removal Kit is designed to specifically remove dsRNA while preserving high recovery of full-length mRNA. We have achieved over 75% recovery for most transcripts.
Immediately after DNase treatment and before the RNA cleanup step.
No. The kit uses a magnetic bead-based workflow that eliminates the need for HPLC or affinity chromatography systems. It only requires a magnetic stand.
Yes. The magnetic bead workflow is compatible with manual and automated liquid handling platforms.
Protein expression, CRISPR genome editing, cell therapy research, vaccine development, iPSC generation and/or differentiation, and 3D cell culture models.
The removal step requires approximately 20 minutes and integrates into existing IVT workflows.
仅供科研使用,不可用于诊断目的。




